Drug Topics e-News:
Having trouble viewing this email? View in a browser.
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Drug Topics e-News
|
|
|
|
 |
 |
Newest: Evolving pharmacy practice in the 21st century
|
| For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here |
|
|
|
|
|
|
|
This month we would like to know...
Approximately how much of your workday is spent dealing with insurance matters?
* 1/4 or less
* up to 1/3
* up to 1/2
* up to 2/3
* 3/4 or more
 |
|
|
ASHP and other associations urge Congress to pass legislation that will ease drug shortages
Executives with the American Society of Health-System Pharmacists and other groups are urging Congress to pass federal legislation to ease drug shortages in the United States. Read full article. |
 |
 |
Do you tweet?
Follow Drug Topics on Twitter to get up-to-the-minute access to FDA approvals, industry news, and more!
Click Here |
|
SAMHSA reports 10 years of trends in alcohol- and substance-abuse treatment
The United States Department of Health and Human Services division of Substance Abuse and Mental Health Services Administration has released a study examining trends of admissions to U.S. substance abuse treatment facilities of people aged 12 years and over, during the period from 1998 to 2008. Read full article. |
|
DT Blog
|
A discussion generated by Drug Topics’ readers, editorial staff, and advisory board
David Stanley, RPh |
Patient Counseling: Walking a tightrope
Read full article.
|
Study proves that even with increased drug costs, adherence will reduce overall health spending
A new study conducted by CVS Caremark and published in Health Affairs, found that among patients who had increased drug costs but were adherent with their medications, a “substantial medical savings as a result of reductions in hospitalization and emergency department use” was realized. Read full article. |
|
HHS brief examines factors affecting generic use and cost savings
With several blockbusters going off patent, Secretary Kathleen Sebelius of the U.S. Department of Health and Human Services asked the office of the Assistant Secretary for Planning and Evaluation to “examine barriers to and identify opportunities for increasing generic use.” Read full article. |
|
Obesity may increase risk of death from H1N1
Researchers recently found that extreme obesity can increase patients’ risk of death from the H1N1 influenza virus. Read full article. |
|
Pfizer launches dual-chamber syringe for patients with hemophilia
Pfizer Inc. recently launched a syringe that aims to help hemophilia patients lead active lives and take care of their condition faster and easier. Read full article. |
|
Merck halts vorapaxar study over bleeding concerns in stroke victims
Concern that its drug vorapaxar, in trial for its potential to prevent clots, actually increased the risk of bleeding in stroke victims has prompted Merck & Co. to halt a late-stage study of the drug, the Associated Press reported. Read full article. |
|
FDA sends complete response letter to MannKind regarding new inhaler
FDA has sent MannKind Corp. a complete response letter regarding the company's New Drug Application for Afrezza (insulin human [rDNA origin]) Inhalation Powder for the treatment of adult patients with types 1 and 2 diabetes for the control of hyperglycemia. Read full article. |
|
Meetings and Events
February 6-8, 2011 NACDS Regional Chain Conference
Naples, FL
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-837-4300
February 13, 2011 19th Annual WILLIAM R. BACON MEMORIAL Breakfast
6:30 a.m. - 8:45 a.m.
Palm Springs, CA
Contact:
800-333-7535; 760-325-6611
March 9-10, 2011 NACDS RxIMPACT Day on Capitol Hill
Washington, DC
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
[email protected]
March 13-15, 2011 NACDS Supply Chain & Logistics Conference
San Diego, CA
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678
March 25-28, 2011 American Pharmacists Annual Meeting
Seattle, WA
Contact:
2215 Constitution Avenue, NW
Washington, DC 20037
Phone: 1-800-237-2742 (APhA)
Fax: 202-448-8734
|
|
|
|
| Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
